{"organizations": [], "uuid": "2da9f1a61010acfddcaef5ee09b83b9cc831e9d0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-broadfin-capital-reports-5-percent/brief-broadfin-capital-reports-5-percent-passive-stake-in-la-jolla-pharmaceutical-sec-filing-idUSFWN1P60WS", "country": "US", "domain_rank": 408, "title": "BRIEF-Broadfin Capital Reports 5 Percent Passive Stake In La Jolla Pharmaceutical - SEC Filing‍​", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-12T00:12:00.000+02:00", "replies_count": 0, "uuid": "2da9f1a61010acfddcaef5ee09b83b9cc831e9d0"}, "author": "", "url": "https://www.reuters.com/article/brief-broadfin-capital-reports-5-percent/brief-broadfin-capital-reports-5-percent-passive-stake-in-la-jolla-pharmaceutical-sec-filing-idUSFWN1P60WS", "ord_in_thread": 0, "title": "BRIEF-Broadfin Capital Reports 5 Percent Passive Stake In La Jolla Pharmaceutical - SEC Filing‍​", "locations": [], "entities": {"persons": [], "locations": [{"name": "la", "sentiment": "none"}], "organizations": [{"name": "sec", "sentiment": "negative"}, {"name": "brief-broadfin capital reports", "sentiment": "negative"}, {"name": "jolla pharmaceutical co", "sentiment": "none"}, {"name": "la jolla pharmaceutical - sec filing‍​ reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "la jolla pharmaceutical co", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 11 (Reuters) - La Jolla Pharmaceutical Co:\n* BROADFIN CAPITAL LLC REPORTS 5 PERCENT PASSIVE STAKE IN LA JOLLA PHARMACEUTICAL CO AS OF JAN 9 - SEC FILING‍​ Source text: ( bit.ly/2D4NbRm ) Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.", "external_links": [], "published": "2018-01-12T00:12:00.000+02:00", "crawled": "2018-01-12T00:24:37.008+02:00", "highlightTitle": ""}